Prostate Cancer Imaging
Clinical research in prostate cancer is centered on PET/CT imaging for identifying disease spread before surgery, with particular attention to pelvic lymph node metastasis in men with newly diagnosed, higher-risk disease.
- PSMA-targeted imaging
- Pelvic lymph node assessment
- Pre-prostatectomy staging
The sponsor’s activity in this area reflects a focus on diagnostic oncology and the use of molecular imaging to improve detection of nodal involvement in prostate malignancy.
Molecular Radiopharmaceuticals
Research activity includes the clinical evaluation of copper Cu 64 PSMA I&T as a radiotracer designed for targeted visualization of prostate-specific membrane antigen-expressing disease.
- Radiotracer-based detection
- PSMA expression imaging
- Nuclear medicine diagnostics
This work sits within molecular imaging and radiopharmaceutical development, supporting clinical assessment of disease localization in oncology.
Surgical Planning Support
The funded trials address imaging needs relevant to treatment planning in patients being considered for prostatectomy, with emphasis on clarifying nodal status prior to intervention.
- Preoperative staging
- Metastatic spread detection
- Risk-stratified prostate cancer care
These studies connect oncologic imaging with decision-making in urologic cancer management.
